About the Company
We do not have any company description for Scinai Immunotherapeutics Ltd. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd. (SCNI) Q2 2024 Earnings Call Transcript
Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) Q2 2024 Results Conference Call August 20, 2024 11:00 AM ETCompany ParticipantsLiat Halpert - Head of Business ...
BiondVax Pharmaceuticals Ltd. Rebrands as Scinai Immunotherapeutics Ltd ...
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological ...
Scinai Immunotherapeutics Ltd. Sponsored ADR
View Scinai Immunotherapeutics Ltd. Sponsored ADR SCNI stock quote prices, financial information, real-time forecasts, and company news from CNN.
SCINAI IMMUNOTHERAPEUTICS ANNOUNCES $10 MILLION STANDBY EQUITY PURCHASE ...
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai" or the "Company"), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and providing ...
Scinai Immunotherapeutics Ltd. to participate this week in H.C ...
JERUSALEM, Sept. 11, 2023 (GLOBE NEWSWIRE) -- via IBN -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company formerly known as BiondVax Pharmaceuticals Ltd., announced today ...
Scinai Immunotherapeutics Ltd.: Scinai Announces Annual Financial ...
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I ...
Scinai Immunotherapeutics CEO Issues Letter to Shareholders
JERUSALEM, Jan. 4, 2024/ PRNewswire/-- Scinai Immunotherapeutics Ltd., a biopharmaceutical company focused on development of inflammation and immunology biological products, today published a ...
Scinai Immunotherapeutics Ltd.: Scinai Immunotherapeutics CEO Issues ...
JERUSALEM, Jan. 4, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), a biopharmaceutical company focused on development of inflammation and immunology (I&I) biological products ...
Scinai Immunotherapeutics Short Interest Report - Benzinga
Short interest in Scinai Immunotherapeutics Ltd (NASDAQ:SCNI) decreased during the last reporting period, falling from 4.95K to 430.00. This put 0.15% of the company's publicly available shares short.
Similar Companies
Loading the latest forecasts...